Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LGD-6972 in Type 2 Diabetes Mellitus
NCT02851849Phase 2Completed
- Sponsor
- Ligand Pharmaceuticals
- Start
- Sep 2016
- Primary completion
- Jun 2017
- Countries
- 1
01
Overview
A Phase 2 trial of LGD-6972 in type 2 diabetes mellitus (T2DM), sponsored by Ligand Pharmaceuticals. Started Sep 2016; status: completed.
02
Drugs
LGD-6972
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02851849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02851849.